<DOC>
	<DOCNO>NCT02222883</DOCNO>
	<brief_summary>The aim prospective registration translational research study evaluate praevalence BRCA regard germline somatic mutation .</brief_summary>
	<brief_title>Prevalence BRCA Patients With Ovarian Cancer</brief_title>
	<detailed_description>Explorative analysis perform .</detailed_description>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<criteria>Female ovarian cancer patient age &gt; = 18 year . Women first diagnosis epithelial ovarian cancer OR woman diagnose platinumsensitive recurrent ovarian cancer . Multiple platinum base prior therapy allow . Nonepithelial ovarian malignancy . Platinumresistant refractory disease . Paraffin embed tumor sample available .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>